Oncopeptides AB (ONPPF)
0.265
0.00 (0.00%)
USD |
OTCM |
May 20, 16:00
Oncopeptides Profit Margin (Quarterly): -1.45K% for Sept. 30, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -1.45K% |
| June 30, 2023 | -217.0% |
| March 31, 2023 | -6.32K% |
| December 31, 2022 | -16.27K% |
| September 30, 2022 | |
| June 30, 2022 | -683.5% |
| Date | Value |
|---|---|
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | -1.43K% |
| June 30, 2021 | -36.33% |
| March 31, 2021 | -1.21K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-16.27K%
Minimum
Dec 2022
-36.33%
Maximum
Jun 2021
-3.45K%
Average
-1.32K%
Median
Profit Margin (Quarterly) Benchmarks
| Abliva AB | -18.42K% |
| Karolinska Development AB | 44.16% |
| Calliditas Therapeutics AB | -4.07% |
| Olink Holding AB | -55.87% |
| BioInvent International AB | -1.31K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -108.3% |
| Return on Assets | -71.90% |
| Return on Invested Capital | -92.02% |
| Operating Margin (Quarterly) | -1.33K% |